Search results for " amyloid"

showing 10 items of 130 documents

Detection of Left Ventricular Systolic Dysfunction in Cardiac Amyloidosis with Strain Rate Echocardiography .

2006

Background We examined the potential role of Doppler myocardial imaging including tissue velocity imaging, strain imaging, and strain rate imaging for detection of left ventricular systolic dysfunction in cardiac amyloidosis (CA) and determined the minimum dataset required to make the diagnosis. Methods and Results Doppler myocardial imaging was performed in 103 patients with amyloidosis (AL). Peak longitudinal systolic tissue velocity, systolic strain rate (sSR), and systolic strain (sS) were determined for 16 left ventricular segments. Radial and circumferential sSR and sS were also measured. Patients with increased left ventricular wall thickness were classified with advanced-CA, and the…

Malemedicine.medical_specialtySystoleBiopsyHeart VentriclesSeverity of Illness IndexDiagnosis DifferentialVentricular Dysfunction LeftSystolic strainInternal medicineHumansMedicineRadiology Nuclear Medicine and imagingAgedRetrospective StudiesTissue velocityEchocardiography Doppler PulsedObserver Variationbusiness.industryAmyloidosisReproducibility of ResultsStrain imagingMiddle AgedStrain ratePrognosismedicine.diseaseMyocardial ContractionSettore MED/11 - Malattie Dell'Apparato CardiovascolareCardiac amyloidosisAMYLOIDOSISStrain rate imagingCardiologyCardiology and Cardiovascular MedicinebusinessBlood Flow VelocityLeft ventricular wallFollow-Up Studies
researchProduct

Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis o…

2012

Aims To determine the role of assessing right ventricular (RV) function, using standard echocardiography and Doppler myocardial imaging (DMI), in the early diagnosis of cardiac amyloidosis and in the prediction of mortality. Methods and results Patients with primary systemic (AL) amyloidosis seen at our institution from 1 February 2004 through 31 October 2005 (N = 249) were categorized by left ventricular thickness and E′ velocity and compared with 38 age- and sex-matched controls. Standard echocardiographic and DMI examination were used to measure echocardiographic parameters of RV function: systolic tissue velocity, strain rate, and strain were determined for basal and middle RV free wall…

Malemedicine.medical_specialtyVentricular Dysfunction RightRisk AssessmentStatistics NonparametricElectrocardiographyInternal medicineImage Interpretation Computer-AssistedmedicineAL amyloidosisHumansRadiology Nuclear Medicine and imagingImmunoglobulin Light-chain Amyloidosiscardiovascular diseasesProspective StudiesSystoleProspective cohort studystrain imaging amyloidosis.medicine.diagnostic_testbusiness.industryAmyloidosisReproducibility of ResultsGeneral MedicineAmyloidosisMiddle Agedmedicine.diseaseSurvival AnalysisSettore MED/11 - Malattie Dell'Apparato CardiovascolareEchocardiography Dopplermedicine.anatomical_structureCardiac amyloidosisROC CurveVentricleStrain rate imagingCase-Control Studiescardiovascular systemCardiologyFemaleRadiologyTricuspid ValvebusinessCardiology and Cardiovascular MedicineElectrocardiographyBiomarkers
researchProduct

In Situ Characterization of Hfq Bacterial Amyloid: A Fourier-Transform Infrared Spectroscopy Study

2019

Hfq is a bacterial protein that regulates gene expression at the post-transcriptional level in Gram-negative bacteria. We have previously shown that Escherichia coli Hfq protein, and more precisely its C-terminal region (CTR), self-assembles into an amyloid-like structure in vitro. In the present work, we present evidence that Hfq unambiguously forms amyloid structures also in vivo. Taking into account the role of this protein in bacterial adaptation and virulence, our work opens possibilities to target Hfq amyloid self-assembly and cell location, with potential to block bacterial adaptation and treat infections. Fil: Partouche, David. Centre National de la Recherche Scientifique; Francia. …

Microbiology (medical)AmyloidOtras Ingenierías y Tecnologíasprotein fibrillation inhibitionVirulencelcsh:MedicineINGENIERÍAS Y TECNOLOGÍASmedicine.disease_causeArticleHFQHfq03 medical and health sciencesIn vivoGene expressionmedicineImmunology and Allergybacterial amyloidSerum amyloid Aprotein fibrilsMolecular BiologyEscherichia coli030304 developmental biology//purl.org/becyt/ford/2.11 [https]Hfq protein0303 health sciencesGeneral Immunology and Microbiologybiology030306 microbiologyChemistrylcsh:Rfunctional amyloidbiology.organism_classificationCell biologyInfectious Diseases//purl.org/becyt/ford/2 [https]FTIRbiology.proteinBacteriaPathogens
researchProduct

DesMol2, an Effective Tool for the Construction of Molecular Libraries and Its Application to QSAR Using Molecular Topology

2019

A web application, DesMol2, which offers two main functionalities, is presented: the construction of molecular libraries and the calculation of topological indices. These functionalities are explained through a practical example of research of active molecules to the formylpeptide receptor (FPR), a receptor associated with chronic inflammation in systemic amyloidosis and Alzheimer&rsquo

Models MolecularMultilinear mapQuantitative structure–activity relationshiplinear discriminant analysisComputer scienceQuantitative Structure-Activity RelationshipPharmaceutical ScienceComputational biology01 natural sciencesArticleAnalytical ChemistrySmall Molecule Librarieslcsh:QD241-44103 medical and health scienceslcsh:Organic chemistryDrug DiscoveryPhysical and Theoretical ChemistryPiperazineDesMol2030304 developmental biology0303 health sciencesMolecular Structure010405 organic chemistryOrganic Chemistrymolecular librariesBase (topology)Linear discriminant analysisReceptors Formyl PeptideSystemic amyloidosis0104 chemical sciencestopology descriptorsmultilinear regression analysisDiscriminantChemistry (miscellaneous)Molecular MedicineMultiple linear regression analysisMolecular topologyAlzheimer’s diseaseDatabases ChemicalSoftwareProtein BindingMolecules
researchProduct

Motor Conduction Studies and Handgrip in Hereditary TTR Amyloidosis: Simple Tools to Evaluate the Upper Limbs

2022

PurposeHereditary transthyretin amyloidosis with polyneuropathy (ATTRv) is caused by mutations in the TTR gene, leading to misfolded monomers that aggregate generating amyloid fibrils. The clinical phenotype is heterogeneous, and characterized by a multisystemic disease affecting the sensorimotor and autonomic functions along with other organs.Materials and MethodsAll the patients were assessed by complete neurological assessment, neurophysiological evaluation, of the median nerve, and handgrip analysis. The data are presented as means and standard deviations. Parametric and non-parametric assessments have been performed to identify differences between groups. Pearson's correlation has been…

Neurologyhandgripcarpal tunnel syndromemedian nervehand strengthnerve conduction study - NCSNeurology (clinical)hereditary amyloid neuropathyneurophysiologyTTRFrontiers in Neurology
researchProduct

From Small Peptides to Large Proteins against Alzheimer'sDisease.

2022

Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the elderly. The two cardinal neuropathological hallmarks of AD are the senile plaques, which are extracellular deposits mainly constituted by beta-amyloids, and neurofibrillary tangles formed by abnormally phosphorylated Tau (p-Tau) located in the cytoplasm of neurons. Although the research has made relevant progress in the management of the disease, the treatment is still lacking. Only symptomatic medications exist for the disease, and, in the meantime, laboratories worldwide are investigating disease-modifying treatments for AD. In the present review, results centered on the use of peptides of different sizes invol…

NeuronsAmyloid beta-Peptidesamyloid-beta protein: amyloid fibrillationAlzheimer DiseaseTau proteinHumanstau ProteinsPlaque AmyloidNeurofibrillary TanglesMolecular BiologyBiochemistryAlzheimer’s diseaseAgedBiomolecules
researchProduct

Designing trehalose-conjugated peptides for the inhibition of Alzheimer’s Aβ oligomerization and neurotoxicity

2008

Neurotoxicity Alzheimer Amyloidsbeta-sheet breaker peptides • amyloid-beta • trehalose • SFM • neuronal cultures • thioflavin T
researchProduct

Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative da…

2001

In the aging dog brain lesions develop spontaneously. They share some morphological characteristics with those of Alzheimer 's disease in man. Diffuse and primitive plaques are well known, whereas neuritic plaques rarely develop. Neurofibrillary tangles have not been seen in the canine. The aim of the present investigation was to study major age-related changes of the dog's brain using paraffin sections with respect to cross-immunoreactivity of tau, A beta protein and other immunoreactive components including hydroxynonenal protein, which is a marker for oxidative damage. The occurrence of neurofibrillary tangles and of the protein tau therein was studied in serial brain sections of two dog…

Pathologymedicine.medical_specialtyAgingAmyloidmedicine.drug_classTau proteinModels NeurologicalNerve Tissue ProteinsPlaque AmyloidMonoclonal antibodymedicine.disease_causeDogsAlzheimer DiseaseInternal MedicinemedicineAnimalsHumansSenile plaquesDog DiseasesAldehydesbiologyChemistryBrainNeurofibrillary Tanglesmedicine.diseaseImmunohistochemistryOxidative StressPolyclonal antibodiesbiology.proteinImmunohistochemistryAlzheimer's diseaseOxidative stressAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
researchProduct

Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus

2012

Dystrophic neurites associated with amyloid plaques precede neuronal death and manifest early in Alzheimer's disease (AD). In this work we have characterized the plaque-associated neuritic pathology in the hippocampus of young (4- to 6-month-old) PS1(M146L)/APP(751SL) mice model, as the initial degenerative process underlying functional disturbance prior to neuronal loss. Neuritic plaques accounted for almost all fibrillar deposits and an axonal origin of the dystrophies was demonstrated. The early induction of autophagy pathology was evidenced by increased protein levels of the autophagosome marker LC3 that was localized in the axonal dystrophies, and by electron microscopic identification…

Pathologymedicine.medical_specialtyNeuriteClinical NeurologyHippocampusMice TransgenicPlaque AmyloidAmyloid plaquesBiologyHippocampal formationHippocampusDystrophic neuritesPathology and Forensic MedicineAmyloid beta-Protein PrecursorMiceCellular and Molecular NeuroscienceAlzheimer DiseaseAutophagyNeuritesmedicineElectron microscopyLC3AnimalsSenile plaquesMicroscopy ImmunoelectronNeuronsSynaptosomeOriginal PaperPS1/APP transgenic miceCytoplasmic VesiclesAutophagymedicine.diseaseAxonsDisease Models AnimalPresynaptic terminalsAxoplasmic transportNeurology (clinical)Alzheimer's disease
researchProduct

Heterocyclic Scaffolds for the Treatment of Alzheimer's Disease

2016

Background: The treatment and diagnosis of Alzheimer’s Disease (AD) are two of the most urgent goals for research around the world. The cognitive decline is generally associated with the elevated levels of extracellular senile plaques, intracellular neurofibril- lary tangles (NFTs), and with a progressive shutdown of the cholinergic basal forebrain neurons transmission. Even if several key targets are under fervent investigation in the cure of AD, till now, the only approved therapeutic strategy is the treatment of symptoms by using cholinesterases inhibitors. It has been demonstrated that both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes are not only responsible of…

Pathologymedicine.medical_specialtyTau proteinDisease010402 general chemistry01 natural scienceschemistry.chemical_compoundAlzheimer DiseaseHeterocyclic CompoundsDrug DiscoverymedicineAnimalsHumansSenile plaquesCognitive declineButyrylcholinesterasePharmacologybiologyMolecular Structure010405 organic chemistryChemistryAcetylcholinesterase0104 chemical sciencesbiology.proteinCholinergicNeuroscienceAmyloid precursor protein secretaseAlzheimer’s disease amyloid-peptide secretase acetylcholinesterase tau protein heterocycles
researchProduct